Abstract
Human biomonitoring (HBM) aims to determine internal exposure to chemicals and related effects. Similar to environmental monitoring, HBM is a basic method for the protection of human health in case of exposure to chemical substances. About 200 chemicals can be analyzed by HBM. In many countries broad general population HBM programs have been established. HBM data are evaluated by reference values and health-based values. Interpretation of HBM data in exposure assessment and health risk context increases its utility and input into risk assessment and risk management.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Angerer J, Ewers U, Wilhelm M (2007) Human biomonitoring: state of the art. Int J Hyg Environ Health 210:201–228
Angerer J, Aylward LL, Hays SM, Heinzow B, Wilhelm M (2011) Human biomonitoring assessment values: approaches and data requirements. Int J Hyg Environ Health 214:348–360
Aylward LL, Kirman CR, Schoeny R, Portier CJ, Hays SM (2012) Evaluation of biomonitoring data from the CDC National Exposure Report in a risk assessment context: perspectives across chemicals. Environ Health Perspect. https://doi.org/10.1289/ehp.1205740. Online 11 Dec 2012
Hays SM, Aylward LL (2012) Interpretation human biomonitoring data in a public health risk concept using biomonitoring equivalents. Int J Hyg Environ Health 215:145–148
Kolossa-Gehring M, Becker K, Conrad A, Schröter-Kermani C, Schulz C, Seiwert M (2012) Environmental surveys, specimen bank and health related environmental monitoring in Germany. Int J Hyg Environ Health 215:120–126
Needham LL, Calafat AM, Barr DB (2007) Uses and issues of biomonitoring. Int J Hyg Environ Health 210:229–238
Schulz C, Wilhelm M, Heudorf U, Kolossa-Gehring M (2011) Update of the reference and HBM values derived by the German Human Biomonitoring Commission. Int J Hyg Environ Health 215:26–35
Wilhelm M, Heinzow B, Angerer J, Schulz C (2010) Reassessment of critical lead effects by the German Human Biomonitoring Commission results in suspension of the human biomonitoring values (HBM-I and HBM-II) for lead in blood of children and adults. Int J Hyg Environ Health 213:265–269
Resources
Knudsen L, Merlo DF (eds) (2012) Biomarkers and human biomonitoring, vol 1. The Royal Society of Chemistry. https://doi.org/10.1039/9781849733373
Summit Toxicology: http://www.summittoxicology.com/publications.html
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer-Verlag GmbH Germany, part of Springer Nature
About this entry
Cite this entry
Wilhelm, M. (2020). Human Biomonitoring: Its Importance in Toxicological Regulation. In: Reichl, FX., Schwenk, M. (eds) Regulatory Toxicology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-36206-4_84-2
Download citation
DOI: https://doi.org/10.1007/978-3-642-36206-4_84-2
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-36206-4
Online ISBN: 978-3-642-36206-4
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences